Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns
Cytomegalovirus (CMV) is common pathogen in the human population and one of the most causes of intrauterine infections of the fetus. It is a component of the acronym TORCH describing pathogens which are a significant risk factor for miscarrings or serious damage to the fetus. Symptomatic congeni...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2025-01-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/57297 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593867772264448 |
|---|---|
| author | Katarzyna Miedzińska Mateusz Grego Łukasz Stojak Dariusz Popiela Karina Urbańska Filip Kwiatkowski Mateusz Baczewski Witold Czyż |
| author_facet | Katarzyna Miedzińska Mateusz Grego Łukasz Stojak Dariusz Popiela Karina Urbańska Filip Kwiatkowski Mateusz Baczewski Witold Czyż |
| author_sort | Katarzyna Miedzińska |
| collection | DOAJ |
| description |
Cytomegalovirus (CMV) is common pathogen in the human population and one of the most causes of intrauterine infections of the fetus. It is a component of the acronym TORCH describing pathogens which are a significant risk factor for miscarrings or serious damage to the fetus. Symptomatic congenital cytomegalovirus occurs in about 10% of infected newborns and, among of the other things, can cause hearing loosing, vision impairment or cognitive impairment in the children. Importantly, a child who is asymptomatic at the time of delivery is still at risk of developing dysfunctions in the future. Currently there is no effective vaccine against cytomegalovirus. There are attempts to treat pregnant women with antiviral drugs and hyperimmunoglobulins. The treatment is intended to protect the fetus from vertical transmission of the virus or to reduce the effects of infection. An important aspect is the time of starting treatment for the woman and the seroprevalence of expectant mothers. The risk of fetal infection increases with the age of pregnancy. Primary infection of the mother poses a greater danger to the fetus than secondary infection. The key moment of treatment apear to be the first trimester of pregnancy, because it is during this period that the greatest devastation occurs in the rapidly developing fetus. For this reason, the greatest benefit from treatment may be obtained by pregnant women with primary CMV infection in the first trimester of pregnancy. In this article, we will present the problem of congenital cytomegalovirus and describe the current proposals for treatment and prophylaxis used in fetuses and newborns infected with cytomegalovirus, we will present the current state of knowledge about potential side effects of its use.
|
| format | Article |
| id | doaj-art-76736a2fb4654c09ba3263c78cec1e55 |
| institution | Kabale University |
| issn | 2450-3118 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nicolaus Copernicus University in Toruń |
| record_format | Article |
| series | Quality in Sport |
| spelling | doaj-art-76736a2fb4654c09ba3263c78cec1e552025-01-20T08:23:26ZengNicolaus Copernicus University in ToruńQuality in Sport2450-31182025-01-013710.12775/QS.2025.37.57297Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newbornsKatarzyna Miedzińska0https://orcid.org/0009-0005-7388-8885Mateusz Grego1https://orcid.org/0009-0008-4079-2168Łukasz Stojak2https://orcid.org/0009-0008-9910-0445Dariusz Popiela3https://orcid.org/0009-0009-8648-2365Karina Urbańska4https://orcid.org/0000-0002-1981-9281Filip Kwiatkowski5https://orcid.org/0009-0006-3873-1265Mateusz Baczewski6https://orcid.org/0009-0007-2857-5219Witold Czyż7https://orcid.org/0009-0006-4442-990010th Military Clinical Hospital with Polyclinic ul. Powstańców Warszawy 5, 85-681 Bydgoszcz, Poland10th Military Clinical Hospital with Polyclinic ul. Powstańców Warszawy 5, 85-681 Bydgoszcz, Poland10th Military Clinical Hospital with Polyclinic ul. Powstańców Warszawy 5, 85-681 Bydgoszcz, Department of Normal Anatomy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, ul. Łukasiewicza 1, 85-821 Bydgoszcz, PolandMilitary Institute of Aviation Medicine, Krasińskiego 54/56 Street, 01-755 Warsaw, PolandCentral Teaching Hospital of the Medical University of Lodz located at ul. Pomorska 251, 92-213 Lodz, PolandMilitary Institute of Aviation Medicine, Krasińskiego 54/56 Street, 01-755 Warsaw, Poland10th Military Clinical Hospital with Polyclinic ul. Powstańców Warszawy 5, 85-681 Bydgoszcz, PolandCentral Teaching Hospital of the Medical University of Lodz located at ul. Pomorska 251, 92-213 Lodz, Poland Cytomegalovirus (CMV) is common pathogen in the human population and one of the most causes of intrauterine infections of the fetus. It is a component of the acronym TORCH describing pathogens which are a significant risk factor for miscarrings or serious damage to the fetus. Symptomatic congenital cytomegalovirus occurs in about 10% of infected newborns and, among of the other things, can cause hearing loosing, vision impairment or cognitive impairment in the children. Importantly, a child who is asymptomatic at the time of delivery is still at risk of developing dysfunctions in the future. Currently there is no effective vaccine against cytomegalovirus. There are attempts to treat pregnant women with antiviral drugs and hyperimmunoglobulins. The treatment is intended to protect the fetus from vertical transmission of the virus or to reduce the effects of infection. An important aspect is the time of starting treatment for the woman and the seroprevalence of expectant mothers. The risk of fetal infection increases with the age of pregnancy. Primary infection of the mother poses a greater danger to the fetus than secondary infection. The key moment of treatment apear to be the first trimester of pregnancy, because it is during this period that the greatest devastation occurs in the rapidly developing fetus. For this reason, the greatest benefit from treatment may be obtained by pregnant women with primary CMV infection in the first trimester of pregnancy. In this article, we will present the problem of congenital cytomegalovirus and describe the current proposals for treatment and prophylaxis used in fetuses and newborns infected with cytomegalovirus, we will present the current state of knowledge about potential side effects of its use. https://apcz.umk.pl/QS/article/view/57297CytomegalovirusCMVcongenital CMVHiperimmunoglobilinValacyclovirValgancyclovir |
| spellingShingle | Katarzyna Miedzińska Mateusz Grego Łukasz Stojak Dariusz Popiela Karina Urbańska Filip Kwiatkowski Mateusz Baczewski Witold Czyż Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns Quality in Sport Cytomegalovirus CMV congenital CMV Hiperimmunoglobilin Valacyclovir Valgancyclovir |
| title | Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns |
| title_full | Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns |
| title_fullStr | Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns |
| title_full_unstemmed | Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns |
| title_short | Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns |
| title_sort | congenital cytomegalovirus current state of knowledge on the treatment and prevention of fetuses and newborns |
| topic | Cytomegalovirus CMV congenital CMV Hiperimmunoglobilin Valacyclovir Valgancyclovir |
| url | https://apcz.umk.pl/QS/article/view/57297 |
| work_keys_str_mv | AT katarzynamiedzinska congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT mateuszgrego congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT łukaszstojak congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT dariuszpopiela congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT karinaurbanska congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT filipkwiatkowski congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT mateuszbaczewski congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns AT witoldczyz congenitalcytomegaloviruscurrentstateofknowledgeonthetreatmentandpreventionoffetusesandnewborns |